Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Inovio's SynCon vaccine for HPV types 6 and 11 induces CD8+ T cells in mice

Inovio's SynCon vaccine for HPV types 6 and 11 induces CD8+ T cells in mice

Viewpoints: The defeated Blunt Amendment, Obama's $100B Catholic hospital risk, fixing drug shortages

Viewpoints: The defeated Blunt Amendment, Obama's $100B Catholic hospital risk, fixing drug shortages

Survivors of cancer in childhood have higher risk of infertility in later life

Survivors of cancer in childhood have higher risk of infertility in later life

Northern Ireland has higher survival rates for pancreatic cancer, leukaemia

Northern Ireland has higher survival rates for pancreatic cancer, leukaemia

Dept. of Justice lawyers strategize on how to win key SCOTUS votes

Dept. of Justice lawyers strategize on how to win key SCOTUS votes

Ruxolitinib boosts QOL and survival for patients with myelofibrosis

Ruxolitinib boosts QOL and survival for patients with myelofibrosis

NEJM publishes results from two Jakafi Phase III studies on MF

NEJM publishes results from two Jakafi Phase III studies on MF

New NOSH-aspirin appears more effective against cancer

New NOSH-aspirin appears more effective against cancer

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept fourth quarter revenue decreases to $0.2 million

Lack of insurance coverage driving up number of patients who seek dental care in the emergency room

Lack of insurance coverage driving up number of patients who seek dental care in the emergency room

CML patients can benefit from imatinib after unsuccessful interferon therapies

CML patients can benefit from imatinib after unsuccessful interferon therapies

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

FDA, pharmaceutical companies announce solution to cancer drug shortage

FDA, pharmaceutical companies announce solution to cancer drug shortage

Researchers discover how mTOR protein leads to cancer metastasis

Researchers discover how mTOR protein leads to cancer metastasis

FDA approves new supplies of drugs that are facing shortages

FDA approves new supplies of drugs that are facing shortages

Telomerase reactivation in malignant cells after genomic instability causes cancer progression

Telomerase reactivation in malignant cells after genomic instability causes cancer progression

DNA ‘nanorobot’  effectively targets cancer leaving healthy cells untouched: Study

DNA ‘nanorobot’ effectively targets cancer leaving healthy cells untouched: Study

Modified imatinib cancer drug prevents morphine tolerance in rats

Modified imatinib cancer drug prevents morphine tolerance in rats

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

Study reveals immune mechanism for surveillance over EBV infection

Study reveals immune mechanism for surveillance over EBV infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.